AG
EW icon

Amiral Gestion’s Edwards Lifesciences EW Stock Holding History

Amiral Gestion’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.72M Sell
96,389
-130,321
-57% -$10.7M 4.29% 10
2025
Q4 		$19.3M Sell
226,710
-56,085
-20% -$4.6M 7.11% 5
2025
Q3 		$22M Buy
282,795
+172,481
+156% +$13.5M 7.99% 4
2025
Q2 		$8.63M Buy
110,314
+3,644
+3% +$272K 3.72% 9
2025
Q1 		$7.73M Buy
106,670
+15,378
+17% +$1.1M 4.25% 9
2024
Q4 		$6.76M Buy
+91,292
New +$6.39M 4.27% 9

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Amiral Gestion's EW Position: Q1 2026 in Review

Amiral Gestion reduced its Edwards Lifesciences (EW) stake by 57% in Q1 2026, selling an estimated $10.7M and leaving 96,389 shares worth $7.72M. The position accounts for 4.29% of the portfolio, ranked #10.

Amiral Gestion first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $22M in Q3 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Amiral Gestion held 96,389 shares of Edwards Lifesciences worth $7.72M as of Q1 2026.
  • Amiral Gestion sold 130,321 Edwards Lifesciences shares in Q1 2026, an estimated $10.7M.
  • Edwards Lifesciences made up 4.29% of Amiral Gestion's portfolio in Q1 2026, its #10 holding.
  • Amiral Gestion first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Amiral Gestion's Edwards Lifesciences position peaked at $22M in Q3 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Amiral Gestion's 13F filing for Q1 2026, filed 20 Apr 2026.